Cargando…

Calculus Bovis Sativus Improves Bile Acid Homeostasis via Farnesoid X Receptor-Mediated Signaling in Rats With Estrogen-Induced Cholestasis

Cholestatic diseases are characterized by toxic bile acid (BA) accumulation, and abnormal BA composition, which subsequently lead to liver injury. Biochemical synthetic Calculus Bovis Sativus (CBS) is derived from natural Calculus Bovis, a traditional Chinese medicine, which has been used to treat h...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Dong, Yang, Jinyu, Liu, Yanan, He, Wenxi, Zhang, Si, Li, Xiping, Zhang, Chenliang, Liu, Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367682/
https://www.ncbi.nlm.nih.gov/pubmed/30774596
http://dx.doi.org/10.3389/fphar.2019.00048
_version_ 1783393851977760768
author Xiang, Dong
Yang, Jinyu
Liu, Yanan
He, Wenxi
Zhang, Si
Li, Xiping
Zhang, Chenliang
Liu, Dong
author_facet Xiang, Dong
Yang, Jinyu
Liu, Yanan
He, Wenxi
Zhang, Si
Li, Xiping
Zhang, Chenliang
Liu, Dong
author_sort Xiang, Dong
collection PubMed
description Cholestatic diseases are characterized by toxic bile acid (BA) accumulation, and abnormal BA composition, which subsequently lead to liver injury. Biochemical synthetic Calculus Bovis Sativus (CBS) is derived from natural Calculus Bovis, a traditional Chinese medicine, which has been used to treat hepatic diseases for thousands of years. Although it has been shown that CBS administration to 17α-ethinylestradiol (EE)-induced cholestatic rats improves bile flow and liver injury, the involved underlying mechanism is largely unknown. In this study, we showed that CBS administration to EE-induced cholestatic rats significantly decreased serum and hepatic BA levels and reversed hepatic BA composition. DNA microarray analysis suggested that the critical pathways enriched by CBS treatment were bile secretion and primary BA synthesis. These findings led us to focus on the effects of CBS on regulating BA homeostasis, including BA transport, synthesis and metabolism. CBS enhanced hepatic BA secretion by inducing efflux transporter expression and inhibiting uptake transporter expression. Moreover, CBS reduced BA synthesis by repressing the expression of BA synthetic enzymes, CYP7A1 and CYP8B1, and increased BA metabolism by inducing the expression of metabolic enzymes, CYP3A2, CYP2B10, and SULT2A1. Mechanistic studies indicated that CBS increased protein expression and nuclear translocation of hepatic and intestinal farnesoid X receptor (FXR) to regulate the expression of these transporters and enzymes. We further demonstrated that beneficial effects of CBS administration on EE-induced cholestatic rats were significantly blocked by guggulsterone, a FXR antagonist. Therefore, CBS improved BA homeostasis through FXR-mediated signaling in estrogen-induced cholestatic rats. Together, these findings suggested that CBS might be a novel and potentially effective drug for the treatment of cholestasis.
format Online
Article
Text
id pubmed-6367682
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-63676822019-02-15 Calculus Bovis Sativus Improves Bile Acid Homeostasis via Farnesoid X Receptor-Mediated Signaling in Rats With Estrogen-Induced Cholestasis Xiang, Dong Yang, Jinyu Liu, Yanan He, Wenxi Zhang, Si Li, Xiping Zhang, Chenliang Liu, Dong Front Pharmacol Pharmacology Cholestatic diseases are characterized by toxic bile acid (BA) accumulation, and abnormal BA composition, which subsequently lead to liver injury. Biochemical synthetic Calculus Bovis Sativus (CBS) is derived from natural Calculus Bovis, a traditional Chinese medicine, which has been used to treat hepatic diseases for thousands of years. Although it has been shown that CBS administration to 17α-ethinylestradiol (EE)-induced cholestatic rats improves bile flow and liver injury, the involved underlying mechanism is largely unknown. In this study, we showed that CBS administration to EE-induced cholestatic rats significantly decreased serum and hepatic BA levels and reversed hepatic BA composition. DNA microarray analysis suggested that the critical pathways enriched by CBS treatment were bile secretion and primary BA synthesis. These findings led us to focus on the effects of CBS on regulating BA homeostasis, including BA transport, synthesis and metabolism. CBS enhanced hepatic BA secretion by inducing efflux transporter expression and inhibiting uptake transporter expression. Moreover, CBS reduced BA synthesis by repressing the expression of BA synthetic enzymes, CYP7A1 and CYP8B1, and increased BA metabolism by inducing the expression of metabolic enzymes, CYP3A2, CYP2B10, and SULT2A1. Mechanistic studies indicated that CBS increased protein expression and nuclear translocation of hepatic and intestinal farnesoid X receptor (FXR) to regulate the expression of these transporters and enzymes. We further demonstrated that beneficial effects of CBS administration on EE-induced cholestatic rats were significantly blocked by guggulsterone, a FXR antagonist. Therefore, CBS improved BA homeostasis through FXR-mediated signaling in estrogen-induced cholestatic rats. Together, these findings suggested that CBS might be a novel and potentially effective drug for the treatment of cholestasis. Frontiers Media S.A. 2019-02-01 /pmc/articles/PMC6367682/ /pubmed/30774596 http://dx.doi.org/10.3389/fphar.2019.00048 Text en Copyright © 2019 Xiang, Yang, Liu, He, Zhang, Li, Zhang and Liu. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Xiang, Dong
Yang, Jinyu
Liu, Yanan
He, Wenxi
Zhang, Si
Li, Xiping
Zhang, Chenliang
Liu, Dong
Calculus Bovis Sativus Improves Bile Acid Homeostasis via Farnesoid X Receptor-Mediated Signaling in Rats With Estrogen-Induced Cholestasis
title Calculus Bovis Sativus Improves Bile Acid Homeostasis via Farnesoid X Receptor-Mediated Signaling in Rats With Estrogen-Induced Cholestasis
title_full Calculus Bovis Sativus Improves Bile Acid Homeostasis via Farnesoid X Receptor-Mediated Signaling in Rats With Estrogen-Induced Cholestasis
title_fullStr Calculus Bovis Sativus Improves Bile Acid Homeostasis via Farnesoid X Receptor-Mediated Signaling in Rats With Estrogen-Induced Cholestasis
title_full_unstemmed Calculus Bovis Sativus Improves Bile Acid Homeostasis via Farnesoid X Receptor-Mediated Signaling in Rats With Estrogen-Induced Cholestasis
title_short Calculus Bovis Sativus Improves Bile Acid Homeostasis via Farnesoid X Receptor-Mediated Signaling in Rats With Estrogen-Induced Cholestasis
title_sort calculus bovis sativus improves bile acid homeostasis via farnesoid x receptor-mediated signaling in rats with estrogen-induced cholestasis
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367682/
https://www.ncbi.nlm.nih.gov/pubmed/30774596
http://dx.doi.org/10.3389/fphar.2019.00048
work_keys_str_mv AT xiangdong calculusbovissativusimprovesbileacidhomeostasisviafarnesoidxreceptormediatedsignalinginratswithestrogeninducedcholestasis
AT yangjinyu calculusbovissativusimprovesbileacidhomeostasisviafarnesoidxreceptormediatedsignalinginratswithestrogeninducedcholestasis
AT liuyanan calculusbovissativusimprovesbileacidhomeostasisviafarnesoidxreceptormediatedsignalinginratswithestrogeninducedcholestasis
AT hewenxi calculusbovissativusimprovesbileacidhomeostasisviafarnesoidxreceptormediatedsignalinginratswithestrogeninducedcholestasis
AT zhangsi calculusbovissativusimprovesbileacidhomeostasisviafarnesoidxreceptormediatedsignalinginratswithestrogeninducedcholestasis
AT lixiping calculusbovissativusimprovesbileacidhomeostasisviafarnesoidxreceptormediatedsignalinginratswithestrogeninducedcholestasis
AT zhangchenliang calculusbovissativusimprovesbileacidhomeostasisviafarnesoidxreceptormediatedsignalinginratswithestrogeninducedcholestasis
AT liudong calculusbovissativusimprovesbileacidhomeostasisviafarnesoidxreceptormediatedsignalinginratswithestrogeninducedcholestasis